ELITE PHARMACEUTICALS (ELTP) Director Barry H. Dash Buys 30,000 Shares

What Happened
Barry H. Dash, a director of ELITE PHARMACEUTICALS INC /NV/ (ELTP), purchased 30,000 shares on August 19, 2026, at $0.29 per share for a total of $8,610. The transaction is reported on a Form 4 with transaction code "P" (purchase — open market or private purchase). Insider purchases can be viewed as a positive signal, though this is a relatively small-dollar transaction.

Key Details

• Transaction date: 2026-08-19
• Price per share: $0.29; Shares purchased: 30,000; Total value: $8,610
• Form 4 filed: 2026-09-10 (about 22 days after the transaction) — appears to be a late filing relative to the usual 2-business-day requirement.
• Shares owned after transaction: not specified in the provided filing excerpt.
• Footnotes/plan: none noted in the provided details.
• Accession: 0001324222-26-000001 (reference to the filing)

Context
Code P on Form 4 indicates a purchase (open market or private purchase). This purchase is small in dollar terms, so while it registers as insider buying, it may not materially change ownership or indicate a major shift in insider conviction. The late filing delays public disclosure and reduces immediacy for investors monitoring insider activity.